PortalPublikationenNimotuzumab treatment of malignant gliomas.

Nimotuzumab treatment of malignant gliomas.

Standard

Nimotuzumab treatment of malignant gliomas. / Bode, Udo; Massimino, Maura; Bach, Ferdinand; Zimmermann, Martina; Khuhlaeva, Elena; Westphal, Manfred; Fleischhack, Gudrun.

in: EXPERT OPIN BIOL TH, Jahrgang 12, Nr. 12, 12, 2012, S. 1649-1659.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Bode, U, Massimino, M, Bach, F, Zimmermann, M, Khuhlaeva, E, Westphal, M & Fleischhack, G 2012, 'Nimotuzumab treatment of malignant gliomas.', EXPERT OPIN BIOL TH, Jg. 12, Nr. 12, 12, S. 1649-1659. <http://www.ncbi.nlm.nih.gov/pubmed/23043252?dopt=Citation>

APA

Bode, U., Massimino, M., Bach, F., Zimmermann, M., Khuhlaeva, E., Westphal, M., & Fleischhack, G. (2012). Nimotuzumab treatment of malignant gliomas. EXPERT OPIN BIOL TH, 12(12), 1649-1659. [12]. http://www.ncbi.nlm.nih.gov/pubmed/23043252?dopt=Citation

Vancouver

Bode U, Massimino M, Bach F, Zimmermann M, Khuhlaeva E, Westphal M et al. Nimotuzumab treatment of malignant gliomas. EXPERT OPIN BIOL TH. 2012;12(12):1649-1659. 12.

Bibtex

@article{b36ac5d9929a4c3a9f27169e6e922c33,
title = "Nimotuzumab treatment of malignant gliomas.",
abstract = "In spite of new alkylating medication and recently accumulated knowledge about genomics, the prognosis of malignant gliomas remains poor. The introduction of single substances interfering with tumour proliferation dynamics has been disappointing and the lessons learned indicate that a complicated network of proliferation needs time consuming, in-depth analysis in order to more specifically treat now distinguishable subgroups of a disease, which too long was thought of as a uniform entity.",
keywords = "Adult, Humans, Child, Clinical Trials as Topic, Signal Transduction, Antibodies, Monoclonal, Humanized/pharmacokinetics/pharmacology/*therapeutic use, Brain Neoplasms/*drug therapy, Glioma/*drug therapy, Adult, Humans, Child, Clinical Trials as Topic, Signal Transduction, Antibodies, Monoclonal, Humanized/pharmacokinetics/pharmacology/*therapeutic use, Brain Neoplasms/*drug therapy, Glioma/*drug therapy",
author = "Udo Bode and Maura Massimino and Ferdinand Bach and Martina Zimmermann and Elena Khuhlaeva and Manfred Westphal and Gudrun Fleischhack",
year = "2012",
language = "English",
volume = "12",
pages = "1649--1659",
journal = "EXPERT OPIN BIOL TH",
issn = "1471-2598",
publisher = "informa healthcare",
number = "12",

}

RIS

TY - JOUR

T1 - Nimotuzumab treatment of malignant gliomas.

AU - Bode, Udo

AU - Massimino, Maura

AU - Bach, Ferdinand

AU - Zimmermann, Martina

AU - Khuhlaeva, Elena

AU - Westphal, Manfred

AU - Fleischhack, Gudrun

PY - 2012

Y1 - 2012

N2 - In spite of new alkylating medication and recently accumulated knowledge about genomics, the prognosis of malignant gliomas remains poor. The introduction of single substances interfering with tumour proliferation dynamics has been disappointing and the lessons learned indicate that a complicated network of proliferation needs time consuming, in-depth analysis in order to more specifically treat now distinguishable subgroups of a disease, which too long was thought of as a uniform entity.

AB - In spite of new alkylating medication and recently accumulated knowledge about genomics, the prognosis of malignant gliomas remains poor. The introduction of single substances interfering with tumour proliferation dynamics has been disappointing and the lessons learned indicate that a complicated network of proliferation needs time consuming, in-depth analysis in order to more specifically treat now distinguishable subgroups of a disease, which too long was thought of as a uniform entity.

KW - Adult

KW - Humans

KW - Child

KW - Clinical Trials as Topic

KW - Signal Transduction

KW - Antibodies, Monoclonal, Humanized/pharmacokinetics/pharmacology/therapeutic use

KW - Brain Neoplasms/drug therapy

KW - Glioma/drug therapy

KW - Adult

KW - Humans

KW - Child

KW - Clinical Trials as Topic

KW - Signal Transduction

KW - Antibodies, Monoclonal, Humanized/pharmacokinetics/pharmacology/therapeutic use

KW - Brain Neoplasms/drug therapy

KW - Glioma/drug therapy

M3 - SCORING: Journal article

VL - 12

SP - 1649

EP - 1659

JO - EXPERT OPIN BIOL TH

JF - EXPERT OPIN BIOL TH

SN - 1471-2598

IS - 12

M1 - 12

ER -